Top Page
Micro-X Ltd.
(Sydney:MX1)
Micro-X Ltd. (MX1) vs. iShares MSCI Australia ETF (EWA)
Micro-X Ltd. Business Overview & Revenue Model
Micro-X Ltd. Financial Statement Overview
| Breakdown | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 15.22M | 15.01M | 8.97M | 3.77M | 4.25M |
| Gross Profit | 5.74M | -7.11M | -12.33M | -12.96M | -7.69M |
| EBITDA | -14.35M | -14.71M | -19.02M | -13.61M | -9.29M |
| Net Income | -9.77M | -10.75M | -17.09M | -14.73M | -10.07M |
Balance Sheet | |||||
| Total Assets | 26.89M | 30.30M | 31.28M | 44.68M | 33.70M |
| Cash, Cash Equivalents and Short-Term Investments | 3.23M | 5.22M | 10.30M | 30.14M | 18.32M |
| Total Debt | 3.99M | 4.77M | 5.38M | 5.90M | 13.54M |
| Total Liabilities | 12.63M | 13.17M | 12.05M | 10.53M | 18.96M |
| Stockholders Equity | 14.26M | 17.13M | 19.22M | 34.15M | 14.74M |
Cash Flow | |||||
| Free Cash Flow | -6.80M | -11.77M | -19.22M | -10.76M | -11.65M |
| Operating Cash Flow | -6.43M | -10.99M | -18.11M | -9.86M | -9.46M |
| Investing Cash Flow | -369.00K | -779.00K | -1.11M | -901.00K | -2.20M |
| Financing Cash Flow | 4.81M | 6.69M | -612.00K | 22.57M | 28.37M |
Micro-X Ltd. Technical Analysis
Micro-X Ltd. Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
60 Neutral | HK$17.39B | 5.75 | -7.44% | 3.10% | 11.55% | -28.15% | |
54 Neutral | AU$52.83M | ― | -7.59% | ― | 28.89% | 72.95% | |
51 Neutral | AU$153.50M | ― | -58.61% | ― | ― | -74.88% | |
48 Neutral | AU$11.78M | ― | -98.08% | ― | -7.44% | 30.34% | |
47 Neutral | AU$43.37M | ― | -135.33% | ― | -27.58% | 33.69% | |
46 Neutral | AU$111.73M | ― | -52.37% | ― | 471.29% | -4.58% | |
41 Neutral | AU$119.47M | ― | -35.20% | ― | 4.68% | -155.42% |
Micro-X Ltd. Corporate Events
Micro-X Ltd has successfully achieved significant development milestones on time and within budget for its contracts with ARPA-H and Billion Prima, enhancing its position in the health and security markets. The company completed Milestone 3 for a Full Body CT scanner under its ARPA-H contract and Milestone 2 for a baggage and parcel scanning unit with Billion Prima. These achievements underscore Micro-X’s commitment to timely project delivery and its strategic partnerships, which are crucial for its growth and market expansion.
The most recent analyst rating on (AU:MX1) stock is a Buy with a A$0.21 price target. To see the full list of analyst forecasts on Micro-X Ltd. stock, see the AU:MX1 Stock Forecast page.
Micro-X Ltd. has announced the appointment of Mr. Richard Willson as the new Company Secretary, effective May 30, 2025. Mr. Willson brings over 25 years of experience in the technology and resources sectors, with a strong background in corporate governance and financial management. This strategic appointment is expected to strengthen Micro-X’s corporate governance and support its growth ambitions in the health and security markets. The company continues to innovate in x-ray technology and expand its market presence, with significant projects underway in both healthcare and security sectors.
The most recent analyst rating on (AU:MX1) stock is a Buy with a A$0.21 price target. To see the full list of analyst forecasts on Micro-X Ltd. stock, see the AU:MX1 Stock Forecast page.
Micro-X Ltd. has announced the quotation of 171,819 ordinary fully paid securities on the Australian Securities Exchange (ASX) under the code MX1, effective from May 15, 2025. This move is part of an employee incentive scheme and reflects the company’s ongoing efforts to enhance its market presence and operational capabilities.
The most recent analyst rating on (AU:MX1) stock is a Buy with a A$0.21 price target. To see the full list of analyst forecasts on Micro-X Ltd. stock, see the AU:MX1 Stock Forecast page.
Micro-X Ltd. announced a change in the director’s interest, with Patrick O’Brien acquiring 1,428,571 ordinary shares, increasing his total holdings to 10,287,591 shares. This acquisition was made through a company placement approved by shareholders, reflecting confidence in the company’s strategic direction and potential growth, which could impact stakeholders positively by enhancing market confidence.
Micro-X Ltd. announced a change in the director’s interest, with Ilona Meyer acquiring 357,143 ordinary shares through a company placement approved by shareholders. This acquisition increases Meyer’s total holdings to 567,961 fully paid ordinary shares, indicating a significant investment in the company’s future, potentially impacting its market positioning and stakeholder confidence.
Micro-X Ltd. announced a change in the director’s interest, with Jim McDowell acquiring 714,286 ordinary shares through the company’s placement approved at the Extraordinary General Meeting in April 2025. This acquisition increases McDowell’s indirect holding, indicating a vote of confidence in the company’s strategic direction and potential growth, which could positively impact stakeholders and market perception.
Micro-X Ltd. announced a change in the director’s interest, with Director Andrew Hartmann acquiring 357,143 fully paid ordinary shares valued at $25,000. This acquisition was part of a company placement approved by shareholders, potentially strengthening the director’s alignment with company interests and signaling confidence in Micro-X’s future growth.
Micro-X Ltd. has announced the quotation of 2,857,143 ordinary fully paid securities on the Australian Securities Exchange (ASX) with the code MX1, set to be issued on May 8, 2025. This move is part of previously announced transactions and is expected to enhance the company’s market presence and provide additional capital for its operations, potentially impacting its industry positioning and stakeholder interests.